What is Beijing SL Pharmaceutical Co., Ltd.'s (002038.SZ) StockRank?

MoatMap's StockRank for Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) is 28/100, with a Sell signal. This is a composite score combining Quality (49), Value (41), and Momentum (30) factor ranks across MoatMap's 20,000+ stock universe.

Does Beijing SL Pharmaceutical Co., Ltd. have an economic moat?

Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) has a Quality factor score of 49/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Beijing SL Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) is Sell, based on a StockRank of 28/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Beijing SL Pharmaceutical Co., Ltd. in?

Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002038.SZ

SELLREMOVE

Beijing SL Pharmaceutical Co., Ltd. · Healthcare · China · $893M · Avg Vol: $23M/d

StockRank

P/E (TTM)

—

ROE

-9.0%

D/E

—

Dividend %

0.2%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Beijing SL Pharmaceutical does not possess the global scale or advanced manufacturing capabilities required to benefit from the CDMO pricing power cycle. It remains a localized player subject to domestic price controls.

COMPANY DESCRIPTION

Beijing SL Pharmaceutical Co., Ltd. develops and manufactures specialty pharmaceuticals, focusing on cardiovascular, ophthalmic, and oncology therapies. The company is a pioneer in domestic cardiovascular drugs, holding significant market share in target segments like anti-thrombotic therapies. It is an R&D-driven specialty pharmaceutical company with a strong portfolio of first-to-market generic drugs.

FINANCIAL SUMMARY (USD)

Year	2021	2022	2023	2024	2025	CAGR
Revenue	—	155M	151M	98M	92M	-15.9%
EPS	—	0.03	0.06	-0.01	-0.05	78.3%
Shares	—	1.0B	1.0B	1.0B	1.0B	0.0%
Debt	364,994	59M	69M	59M	131M	334.9%
Equity	—	808M	857M	824M	766M	-1.8%
Op CF	—	58M	68M	33M	38M	-12.9%
Inv CF	—	-80M	-51M	-31M	-21M	—
Fin CF	—	-15M	-15M	-23M	-3M	—

PRICE (1M)-19.9%

SMA 50SMA 200

$0.77

RSI (14)

18.3

52W High

$1.39

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

-0.0%44.9

ROE

-9.0%36.1

GP/Assets

6.2%20.2

Op. Margin

26.9%89.7

FCF/Assets

15.5%93.4

Piotroski

—55.8

Int. Cover

—N/A

D/E Ratio

—N/A

Current Ratio

3.38x57.7

Value

P/E (TTM)

—N/A

EV/EBITDA

25.2x14.1

P/FCF

43.7x91.3

P/B

1.1x75.9

P/S

9.2x27.8

Div Yield

0.2%5.3

Momentum

52W High %

55%30.9

RS 6M

-43%26.8

SMA 50/200

0.92x39.9

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$893M

P/E (Forward)

—

Gross Margin

63.2%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002038.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
002038.SZ	Beijing SL Pharmaceutical Co., Ltd.(you)	$893M	28	SELL
688621.SS	Beijing Sun-Novo Pharmaceutical Research Co., Ltd.	$894M	26	SELL
688176.SS	Jiangsu Yahong Meditech Co., Ltd.	$961M	30	SELL
600252.SS	Guangxi Wuzhou Zhongheng Group Co., Ltd	$1.0B	29	SELL
603567.SS	Heilongjiang ZBD Pharmaceutical Co., Ltd.	$994M	26	SELL
300702.SZ	Zhejiang Tianyu Pharmaceutical Co., Ltd.	$989M	26	SELL
002907.SZ	Chongqing Pharscin Pharmaceutical Co., Ltd.	$765M	26	SELL
002940.SZ	Zhejiang AngLiKang Pharmaceutical CO.,LTD.	$1.0B	25	SELL
600422.SS	KPC Pharmaceuticals,Inc.	$999M	24	SELL
002793.SZ	Luoxin Pharmaceuticals Group Stock Co., Ltd.	$690M	31	SELL

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.0%

Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) — Stock Score Summary

Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) has a MoatMap StockRank of 28/100 based on Quality (49/100), Value (41/100), and Momentum (30/100) factor scores. The current signal is SELL. Beijing SL Pharmaceutical does not possess the global scale or advanced manufacturing capabilities required to benefit from the CDMO pricing power cycle. It remains a localized player subject to domestic price controls.

Key Financial Metrics

Price	$0.77
Market Cap	$893M
Price/Book	1.12
Return on Equity	-9.0%
Return on Invested Capital	-0.0%
Gross Margin	63.2%
Operating Margin	26.9%
Revenue Growth	-19.0%
Dividend Yield	0.2%
Free Cash Flow	$20M

Beijing SL Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Beijing SL Pharmaceutical Co., Ltd.’s (002038.SZ) StockRank?: MoatMap’s StockRank for Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) is 28/100, with a Sell signal. It is a composite of Quality (49), Value (41), and Momentum (30) factor ranks across MoatMap’s 20,000+ stock universe.
Does Beijing SL Pharmaceutical Co., Ltd. have an economic moat?: Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) has a Quality factor score of 49/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Beijing SL Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) is Sell, based on a StockRank of 28/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Beijing SL Pharmaceutical Co., Ltd. in?: Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).